Surrozen Reports First Quarter 2026 Financial Results and Provides Business Update Life Science Investing
argenx Announces Results of Annual General Meeting and Board of Directors' Appointment of Karen Massey as Chief Executive Officer Biotech Investing
NanoViricides, Inc. Announces Participation in the D. Boral Capital Global Conference Life Science Investing
Pliant Therapeutics to Participate in the RBC Capital Markets Global Healthcare Conference Life Science Investing
Taysha Gene Therapies Reports First Quarter 2026 Financial Results and Provides Corporate Update Life Science Investing
Novavax Reports First Quarter 2026 Financial Results and Operational Highlights Life Science Investing
Annexon to Present at the Bank of America Securities Health Care Conference 2026 Life Science Investing
BriaCell Receives FDA Clearance to Initiate Bria-BRES+ Clinical Study in Breast Cancer Biotech Investing
Anavex Life Sciences Board of Directors Appoints Former Senior Vice President of Clinical Development Terrie Kellmeyer, PhD, as Interim Chief Executive Officer Life Science Investing
